ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

248 hedge funds and large institutions have $4.11B invested in Alnylam Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 109 increasing their positions, 62 reducing their positions, and 37 closing their positions.

Holders
248
Holders Change
-6
Holders Change %
-2.36%
% of All Funds
6.63%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.21%
New
33
Increased
109
Reduced
62
Closed
37
Calls
$68.7M
Puts
$33.7M
Net Calls
+$35.1M
Net Calls Change
+$29.7M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$222M
2
Dodge & Cox
2
Dodge & Cox
California
$140M
3
DM
3
Deerfield Management
New York
$18.6M
4
JHIU
4
Janus Henderson Investors US
Colorado
$19.9M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$15.4M

Top Sellers

1
Capital World Investors
1
Capital World Investors
California
$31.8M
2
Royal London Asset Management
2
Royal London Asset Management
United Kingdom
$3.91M
3
VAM
3
Visium Asset Management
New York
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Franklin Resources
5
Franklin Resources
California
$32.9M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$712M 12,834,080 +30,785 +0.2%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$664M 11,971,783 +26,176 +0.2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$299M 5,385,509 +182,614 +4%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$222M 3,996,142 +2,712,060 +211%
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$188M 3,390,252 +10,317 +0.3%
Dodge & Cox
6
Dodge & Cox
California
$140M 2,516,669 +2,516,669 New
State Street
7
State Street
Massachusetts
$122M 2,195,504 +258,984 +13%
BIT
8
BlackRock Institutional Trust
California
$107M 1,926,330 +149,671 +8%
BFA
9
BlackRock Fund Advisors
California
$104M 1,870,882 +32,506 +2%
UBS AM
10
UBS AM
Illinois
$92.3M 1,662,882 +10,959 +0.7%
GGHC
11
Gilder Gagnon Howe & Co
New York
$77.4M 1,393,947 -20,684 -1%
BRC
12
Blue Ridge Capital
New York
$73.2M 1,320,000 +245,000 +23%
BB
13
BB Biotech
Switzerland
$66.1M 1,191,338 – –
SPC
14
Slate Path Capital
New York
$63M 1,135,000 – –
Jennison Associates
15
Jennison Associates
New York
$54.1M 975,425 +4,972 +0.5%
Morgan Stanley
16
Morgan Stanley
New York
$48.6M 875,104 -203,778 -19%
RI
17
RTW Investments
New York
$46.2M 832,549 -33,830 -4%
AG
18
Artal Group
Luxembourg
$39.4M 710,000 +110,000 +18%
1WCM
19
12 West Capital Management
New York
$38.8M 700,000 +4,000 +0.6%
Wells Fargo
20
Wells Fargo
California
$38.8M 698,398 -74,653 -10%
Goldman Sachs
21
Goldman Sachs
New York
$38.5M 693,168 +51,294 +8%
BM
22
Bridger Management
New York
$38.1M 687,009 -110,203 -14%
Franklin Resources
23
Franklin Resources
California
$32.9M 592,000 -351,723 -37%
Capital World Investors
24
Capital World Investors
California
$31.8M 573,700 -1,364,903 -70%
BG
25
BlackRock Group
United Kingdom
$30.9M 557,458 +37,624 +7%
1
2 3 4 5